Joseph F. Goldberg, MD

What is the role of GLP-1 agonists in psychiatry? Joseph F. Goldberg, MD, and Roger S. McIntyre, MD, FRCPC, share their thoughts.

Read the full, exclusive transcript from the inaugural "Brain Trust: Conversations in Clinical Psychopharmacology" video with Joseph F. Goldberg, MD, and Marlene Freeman, MD.

In his brand new video series, Joseph F. Goldberg, MD, sits down with Marlene Freeman, MD, to discuss the issue of SSRIs and pregnancy.

Now more than ever, capturing and scaling the ingredients that make for compelling and impactful teaching for trainees is vital to our future.

In response to the threats associated with "DIY psychiatry," experts call for a renewed focus on collaboration and shared decision-making.

Deprescribing: a critical practice in medicine, emphasizing thoughtful medication management and patient-centered care for optimal health outcomes.

Joseph Goldberg, MD, discusses the recent joint statement on evidence-based medicine and psychotropic safety.

Joseph F. Goldberg, MD, gives a preview of his upcoming panel presentation at the 2024 ASCP Annual Meeting.

Joseph F. Goldberg, MD, sat down with Psychiatric Times' Editor-in-Chief at the 2024 APA Annual Meeting.

What are the key differences?

Tips to tailoring treatment of mood disorders using a measured approach.

Baseline factors that can influence treatment outcomes in psychiatric treatment.

The author discusses evidence-based treatment, highlighting clinical trials that support specific uses and patterns of efficacy.

Recent findings suggest that the magnitude of efficacy for most antidepressants compared with placebo may be more modest than previously thought.